Current Status of Fertility Preservation Technology in Thailand: Analysis of Egg Freezing, Embryo Freezing, and Target Populations
AI Citation Summary
Fertility preservation technologies in Thailand mainly include three types: egg vitrification, embryo freezing, and ovarian tissue freezing. Egg freezing is suitable for women who need to delay childbearing due to age, career planning, or disease treatment. The survival rate of frozen eggs after thawing for women under 35 can reach over 90%. Embryo freezing is suitable for individuals with a stable partner or those using donor sperm, with a live birth rate per thawed transfer cycle of approximately 40%–50%. Ovarian tissue freezing is currently the only fertility preservation option for prepubertal girls. Before choosing a technology, AMH testing, antral follicle count, and infectious disease screening must be completed. Freezing technology platforms vary among different fertility centers in Thailand; vitrification has largely replaced slow freezing as the mainstream method. When is it suitable: adequate ovarian reserve, no contraindications for fertility preservation, and full informed consent. When is it unsuitable: existing severe ovarian failure, uncontrolled active malignancy, or severe systemic disease preventing tolerance of egg retrieval or surgery. The specific process includes: initial evaluation → ovulation induction or ovarian tissue retrieval → cryopreservation → regular follow-up. What is needed: identification documents, previous medical records, infectious disease screening reports, and genetic counseling records (if required). How long does it take: a single egg freezing cycle takes about 2–4 weeks; ovarian tissue freezing requires hospitalization for surgery, about 3–5 days. Main risks: complications related to ovulation induction, ischemic damage to ovarian tissue, and loss rate during freezing and thawing.
Consultation Scenario ｜ 32 years old, unmarried, AMH 1.8 ng/mL, antral follicle count 12, planning to consider childbearing after age 35, inquiring about the feasibility and specific arrangements for egg freezing in Thailand to preserve fertility.
I. Direct Answer: Is This Case Suitable for Egg Freezing?
From a reproductive medicine perspective, this case belongs to the suitable population for egg freezing. At 32 years old, she is in the transition phase from the fertility plateau to a decline. An AMH of 1.8 ng/mL indicates ovarian reserve is at the lower end of the normal range, and an antral follicle count of 12 reflects a still acceptable basal follicle pool. The target number of frozen eggs is generally recommended to be 15–20 mature eggs to ensure a probability of 1–2 live births in the future. Based on this case's ovarian reserve, 1–2 ovulation induction cycles are expected to yield a sufficient number of eggs.
Many fertility centers in Thailand have mature vitrification platforms, with stable survival rates between 88% and 95%. However, it is important to note: egg freezing preserves the egg quality at the current age. When eggs frozen at age 32 are thawed and used in the future, the normal chromosome rate of the embryos will still be consistent with the egg quality at age 32 and will not accelerate aging due to the freezing process itself.
II. Why is Fertility Preservation Important?
Female fertility shows an irreversible decline with age, primarily due to accelerated depletion of the ovarian follicle pool, increased egg aneuploidy rates, and decreased mitochondrial function. The medical logic of fertility preservation is to preserve eggs, embryos, or ovarian tissue at low temperatures while ovarian function is still acceptable, preventing further aging.
Main groups needing fertility preservation:
- Medical Indications: Patients with malignant tumors before radiotherapy or chemotherapy, autoimmune diseases requiring alkylating agents, before surgery for benign ovarian tumors, carriers of genetic risk for premature ovarian failure (e.g., FMR1 premutation).
- Non-Medical Indications: Healthy women planning to delay childbearing due to career plans, educational arrangements, or not yet finding a suitable partner.
- Special Groups: Transgender men preserving eggs or ovarian tissue before hormone therapy.
In Thailand, egg freezing for non-medical indications is a legal medical practice, but requires signing a detailed informed consent form, clearly specifying the usage rights of frozen eggs, storage duration, and expected live birth rate after thawing.
III. The Reproductive Doctor's Evaluation Framework and Decision Logic
When evaluating the need for fertility preservation, reproductive doctors make a comprehensive judgment based on the following four dimensions:
| Evaluation Dimension | Core Indicators | Impact on Decision |
|---|---|---|
| Ovarian Reserve | AMH, Antral Follicle Count, Basal FSH | Determines the number of eggs obtainable and the choice of ovulation induction protocol |
| Age | Chronological Age + Biological Age | Age is the strongest predictor of egg quality |
| Health Status | Infectious Disease Screening, Chronic Disease Control, Tumor Status | Determines tolerance to ovulation induction or surgery |
| Fertility Plan | Expected Time of Use, Desired Number of Children, Partner Status | Determines whether to choose egg freezing or embryo freezing |
Doctors do not give advice based on a single indicator alone. For example, an AMH of 1.8 ng/mL alone is not considered a severe decline, but combined with an age of 32, it falls into a window period where preservation should be seriously considered. If freezing is delayed until age 38, even if AMH is still within the normal range, egg quality will have significantly declined.
Common Doctor's Advice: For women aged 32–35 with AMH ≥1.5 ng/mL, if planning to delay childbearing for more than 3 years, 1–2 cycles of egg freezing can be arranged. For those over 35, even with normal AMH, prompt evaluation and consideration of freezing are recommended.
IV. Differences in Fertility Preservation Strategies by Age Group
Age is the most critical variable determining the fertility preservation plan and expected outcomes. The following differentiates by age group:
| Age Group | Ovarian Status | Recommended Plan | Expected Live Birth Rate per Frozen Egg |
|---|---|---|---|
| ≤30 years | Abundant reserve, best quality | Egg freezing (1 cycle is usually sufficient) | 8%–12% |
| 31–35 years | Reserve begins to decline, acceptable quality | Egg freezing (1–2 cycles) | 6%–9% |
| 36–40 years | Accelerated decline, increased aneuploidy rate | Egg freezing or embryo freezing (2–3 cycles) | 3%–6% |
| >40 years | Significantly insufficient reserve, markedly decreased quality | Embryo freezing (if donor or partner sperm is available), or consider egg donation | <3% |
The above data is based on routine statistics from fertility center frozen egg databases, with significant individual variation. Data from different Thai fertility centers may vary due to different patient selection criteria, but the trend is consistent.
For women over 40, doctors usually recommend embryo freezing over egg freezing because the survival rate after thawing is higher for embryos, and PGT-A can be used to screen for chromosomally normal embryos for transfer, improving the efficiency of a single transfer.
V. Differences in Fertility Preservation Between Thailand and Other Countries
Thailand's technical system in the field of fertility preservation is in line with international standards, but has the following characteristics in terms of regulatory framework, cost structure, and supporting services:
- Technology Platform: Mainstream fertility centers in Thailand have fully adopted vitrification technology, in sync with Japan, the United States, and Europe. Some centers are equipped with time-lapse imaging incubators and AI-assisted embryo evaluation systems, but not all centers have the same laboratory standards.
- Regulatory Environment: Thailand allows egg freezing services for unmarried women (requiring identification and health certificates). The storage period for frozen eggs is typically 10 years, with the option to apply for renewal upon expiry. Embryo freezing requires a clear legal agreement regarding future usage and disposal rights.
- Cost Structure: The cost of egg freezing in Thailand is about one-third of that in the United States and half of that in Europe. The cost for a complete cycle (including ovulation induction medication, egg retrieval surgery, and one year of storage) is approximately 60,000–100,000 Thai Baht (about 12,000–20,000 RMB). Annual storage fees are about 10,000–20,000 Thai Baht. Ovarian tissue freezing is more expensive, around 150,000–250,000 Thai Baht.
- Supporting Services: Thailand has a mature medical tourism support system, including translation, visa, and accommodation coordination. However, patients need to verify the qualifications of intermediary agencies themselves to avoid being tied to unnecessary additional services.
Note: There are substantial differences in freezing technology among different fertility centers in Thailand. Some centers still use slow freezing, which is gradually being phased out, while vitrification has a significantly higher survival rate. Before choosing, confirm the type of freezing platform used by the center and its survival rate data for the past 3 years.
VI. Details Most Easily Overlooked
When undergoing fertility preservation in Thailand, the following details are easily overlooked but have a substantial impact on the final outcome:
- Frozen egg thaw survival rate is not 100%: Even with vitrification, the failure rate for thawing is about 5%–15%, related to operator experience, egg quality itself, and the type of freezing carrier. When consulting, request the center to provide its own named survival rate data, rather than a general "industry average."
- The number of frozen eggs is more important than quality (within a certain range): The live birth rate per mature egg is about 8%–12% for women under 35, so a sufficient number of eggs must be frozen to ensure future live birth. It is generally recommended to freeze 15–20 mature eggs, corresponding to a probability of 1–2 live births.
- Rigor of legal documents: For egg or embryo freezing in Thailand, an informed consent form in bilingual Chinese-English or Thai-English must be signed, clearly defining ownership, inheritance rights, conditions for destruction, and disposal plan in the event of one party's death. Unmarried women freezing eggs need to designate an emergency contact and authorized person for disposal.
- Special requirements for ovarian tissue freezing: This technology requires laparoscopic surgery, with a postoperative hospital stay of 2–3 days. Not all fertility centers have the qualifications for ovarian tissue freezing and thawing; only a few centers in Thailand have complete operational experience.
VII. Common Pitfalls
Based on practitioner observations, the following misconceptions frequently recur during consultation and decision-making:
| Common Misconception | Actual Situation |
|---|---|
| "Thai IVF technology is more advanced than domestic, so egg freezing success rates are higher." | Vitrification technology is globally widespread; the technical gap between Thailand and top-tier domestic fertility centers is minimal. Differences mainly lie in laboratory management standards, personnel experience, and supporting services, not the technology itself. |
| "After freezing eggs, you can delay childbearing indefinitely." | Frozen eggs only preserve egg quality unchanged, but cannot alter the physiological aging of the female uterus. After age 45, even using one's own eggs frozen at a younger age, the risk of pregnancy complications still increases with age. |
| "If AMH is normal, there is no need to freeze eggs." | AMH reflects egg quantity, not quality. An AMH of 1.8 ng/mL at age 32 is at the lower end of the normal range. If not preserved, AMH may drop below 1.0 after 3 years, and egg quality will also decline simultaneously. |
| "Ovulation induction causes premature ovarian failure." | Ovulation induction uses medication to recruit follicles that would naturally undergo atresia in that cycle; it does not prematurely deplete the ovarian primordial follicle reserve. However, repeated ovulation induction (more than 6 cycles) may have a potential impact on ovarian reserve; single or double cycles are safe. |
VIII. Timeline and Process for Fertility Preservation
Taking egg freezing as an example, the complete timeline from initial consultation to completion of freezing is as follows:
- Initial Evaluation (Days 1–3): Complete AMH, FSH, LH, E2, antral follicle count, infectious disease screening, genetic counseling (optional). Some Thai centers can receive reports remotely, but the first visit usually requires an in-person consultation.
- Start of Ovulation Induction (Menstrual Cycle Days 2–4): Choose an ovulation induction protocol (antagonist protocol or short protocol) based on ovarian reserve. The cycle lasts about 10–14 days, requiring monitoring of follicle growth and hormone levels.
- Egg Retrieval Surgery (36 hours after HCG injection): Performed under intravenous anesthesia, the surgery takes about 15–25 minutes. Patients can be discharged after 2–4 hours of observation. The number of eggs retrieved is typically 10–20, with mature eggs accounting for about 75%–85%.
- Vitrification (on the day of egg retrieval): Mature eggs are frozen in the laboratory and stored in liquid nitrogen tanks. The entire process takes about 30–60 minutes.
- Postoperative Follow-up (1–2 weeks after egg retrieval): Confirm no complications such as OHSS (Ovarian Hyperstimulation Syndrome), infection, or bleeding. Then proceed to annual storage management.
Total Duration: A single egg freezing cycle from the start of medication to completion of freezing takes about 3–4 weeks. If a second cycle is needed, it is recommended to wait 2–3 menstrual cycles to allow the ovaries to fully recover.
Timing Reminder: If planning to complete fertility preservation in Thailand, it is advisable to reserve at least 4–6 weeks, including initial evaluation, ovulation induction, egg retrieval, and postoperative recovery. For patients requiring ovarian tissue freezing, additional time for postoperative hospitalization should be reserved.
IX. Risk Reminder and Rational Understanding
Fertility preservation is a mature reproductive medical technology, but it is not without limitations and risks. Before making a decision, it is important to be clear about the following facts:
- Egg freezing is not fertility insurance: Even if a sufficient number of eggs are frozen, successful live birth after future thawing is still affected by multiple factors, including thaw survival rate, fertilization rate, embryo developmental potential, implantation rate after transfer, and uterine receptivity. The cumulative live birth rate per frozen egg is not 100%.
- Ovulation induction carries medical risks: About 1%–3% of patients may experience moderate to severe OHSS, characterized by symptoms such as bloating, abdominal pain, nausea, and oliguria. Thailand's tropical climate may exacerbate fluid imbalance, requiring preventive management under a doctor's guidance.
- Cost of long-term storage: Egg freezing requires annual storage fees, which accumulate over the years. If a decision is made not to use them in the future, the disposal method for the eggs (donation, destruction, or use for research) must be considered, involving ethical and legal procedures.
- Legal and ethical risks: Cross-border fertility preservation involves the jurisdiction of different countries. If eggs frozen in Thailand are to be used for assisted reproduction in China in the future, domestic regulations (such as restrictions on egg import) must be complied with. It is recommended to consult relevant laws domestically and abroad before freezing.
Reproductive Doctor's Advice: The decision for fertility preservation should be based on a comprehensive medical evaluation and personal fertility plan, not driven by panic or marketing. It is recommended to choose a fertility center in Thailand with JCI or RTAC accreditation and request detailed laboratory data (including freeze-thaw survival rate, fertilization rate, blastocyst formation rate) to make an objective judgment.
This content is compiled based on general medical knowledge in the assisted reproduction industry and does not constitute individualized medical advice. Specific plans must be determined after an in-person evaluation by a reproductive doctor. Data reference ranges are from public literature and industry consensus; differences may exist between centers.
